🔗 Visit the ClinicalTrials.gov page for NCT04492254
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. | Lancet | 2020 | 18.32 |
| 2 | Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. | JAMA | 2020 | 6.59 |
| 3 | Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. | J Thromb Haemost | 2005 | 5.92 |
| 4 | Two-stage sample size re-estimation based on a nuisance parameter: a review. | J Biopharm Stat | 2005 | 1.42 |
| 5 | Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH. | J Thromb Haemost | 2015 | 0.95 |
| 6 | Anti-Inflammatory Effects of Heparin and Its Derivatives: A Systematic Review. | Adv Pharmacol Sci | 2015 | 0.79 |